At the time of writing, GeneDx Holdings Corp [WGS] stock is trading at $131.76, down -4.15%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WGS shares have gain 8.88% over the last week, with a monthly amount glided 22.29%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on October 20, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $155. Previously, Piper Sandler started tracking the stock with Overweight rating on July 09, 2025, and set its price target to $110. On May 15, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $88 on the stock. Jefferies upgraded its rating to a Buy but stick to its price target of $80 on May 09, 2025. Wells Fargo initiated its recommendation with a Equal Weight and recommended $34 as its price target on August 28, 2024. Craig Hallum started tracking with a Buy rating for this stock on July 10, 2024, and assigned it a price target of $43.
For the past year, the stock price of GeneDx Holdings Corp fluctuated between $55.17 and $146.00. Currently, Wall Street analysts expect the stock to reach $153.75 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $131.76 at the most recent close of the market. An investor can expect a potential return of 16.69% based on the average WGS price forecast.
Analyzing the WGS fundamentals
According to GeneDx Holdings Corp [NASDAQ:WGS], the company’s sales were 402.19M for trailing twelve months, which represents an 51.86% jump. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 126.10 points at the first support level, and at 120.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 141.11, and for the 2nd resistance point, it is at 150.45.
Ratios To Look Out For
It is important to note that GeneDx Holdings Corp [NASDAQ:WGS] has a current ratio of 2.71. Also, the Quick Ratio is 2.59, while the Cash Ratio stands at 1.1. Considering the valuation of this stock, the price to sales ratio is 9.47, the price to book ratio is 13.02 and price to earnings (TTM) ratio is 2185.07.
Transactions by insiders
Recent insider trading involved Stueland Katherine, CHIEF EXECUTIVE OFFICER, that happened on Sep 30 ’25 when 12858.0 shares were sold. CHIEF FINANCIAL OFFICER, Feeley Kevin completed a deal on Sep 30 ’25 to sell 6609.0 shares. Meanwhile, Officer Kevin Feeley bought 5805.0 shares on Sep 30 ’25.
